In-Silico Study of Thiazolidinone-linked Glu-Ureido based PSMA Ligands for PET Applications Article Swipe
Mohd. Faheem
,
Vaibhav Pandey
,
Manisha Prasad
,
Manish Dixit
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.21203/rs.3.rs-7159986/v1
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.21203/rs.3.rs-7159986/v1
Introduction: The Prostate Specific Membrane Antigen (PSMA) is a type II transmembrane glycoprotein known as Glutamate Carboxypeptidase II, overexpressed in prostate carcinoma. The Glu-Ureido moiety is a target-specific inhibitor for PSMA, and these widely used inhibitors show promising results in both non-invasive nuclear imaging and radionuclide-based therapeutic applications for prostate cancer. Materials and Methods In this study, 60 scaffolds based on Glu-Ureido-linked thiazolidinone-based ligands were designed and 10 ligands were virtually screened using various in-silico parameters. These designed scaffolds incorporated fluorine atoms to mimic radiolabelling approaches and evaluate their potential as imaging agents. The compounds were evaluated using DFT, ADMET profiling, toxicity analysis, molecular docking and dynamics. Results The selected molecules are screened based on target prediction, DFT, toxicity and other selected parameters. Among the screened compounds, PSMA-THL02, PSMA-THL04, PSMA-THL06, PSMA-THL07, PSMA-THL08 and PSMA-THL10 exhibited the lowest binding energy scores and passed other parameters, indicating them as potent scaffolds for the PSMA. Discussion The good docking score and other physicochemical properties suggest that Glu-Ureido-linked thiazolidinone scaffolds are promising candidates for PSMA-targeted imaging. Among the library, the PSMA-THL02, PSMA-THL06, PSMA-THL07, PSMA-THL08, and PSMA-THL10 are the promising scaffolds for prostate cancer imaging. The presence of fluorine atoms not only simulates potential radionuclide tagging but may also enhance receptor binding and molecular stability. These findings support the potent scaffolds for imaging and therapeutics from the selected candidates. Conclusion Among the selected library, the Glu-Ureido-based thiazolidinone ligands, particularly PSMA-THL02, THL04, THL06, THL07, THL08, and THL10, are potent scaffolds with specificity toward PSMA. These scaffolds represent promising candidates for future development as diagnostic and therapeutic radiotracers in the management of prostate cancer.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.21203/rs.3.rs-7159986/v1
- https://www.researchsquare.com/article/rs-7159986/latest.pdf
- OA Status
- gold
- References
- 47
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4413894307
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4413894307Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.21203/rs.3.rs-7159986/v1Digital Object Identifier
- Title
-
In-Silico Study of Thiazolidinone-linked Glu-Ureido based PSMA Ligands for PET ApplicationsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-01Full publication date if available
- Authors
-
Mohd. Faheem, Vaibhav Pandey, Manisha Prasad, Manish DixitList of authors in order
- Landing page
-
https://doi.org/10.21203/rs.3.rs-7159986/v1Publisher landing page
- PDF URL
-
https://www.researchsquare.com/article/rs-7159986/latest.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.researchsquare.com/article/rs-7159986/latest.pdfDirect OA link when available
- Concepts
-
In silico, Chemistry, Computational biology, Combinatorial chemistry, Pharmacology, Biochemistry, Medicine, Biology, GeneTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
47Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4413894307 |
|---|---|
| doi | https://doi.org/10.21203/rs.3.rs-7159986/v1 |
| ids.doi | https://doi.org/10.21203/rs.3.rs-7159986/v1 |
| ids.openalex | https://openalex.org/W4413894307 |
| fwci | 0.0 |
| type | article |
| title | In-Silico Study of Thiazolidinone-linked Glu-Ureido based PSMA Ligands for PET Applications |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11440 |
| topics[0].field.id | https://openalex.org/fields/16 |
| topics[0].field.display_name | Chemistry |
| topics[0].score | 0.9988999962806702 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1605 |
| topics[0].subfield.display_name | Organic Chemistry |
| topics[0].display_name | Click Chemistry and Applications |
| topics[1].id | https://openalex.org/T10911 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9983999729156494 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Chemical Synthesis and Analysis |
| topics[2].id | https://openalex.org/T11686 |
| topics[2].field.id | https://openalex.org/fields/25 |
| topics[2].field.display_name | Materials Science |
| topics[2].score | 0.9972000122070312 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2507 |
| topics[2].subfield.display_name | Polymers and Plastics |
| topics[2].display_name | Dendrimers and Hyperbranched Polymers |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2775905019 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9094047546386719 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q192572 |
| concepts[0].display_name | In silico |
| concepts[1].id | https://openalex.org/C185592680 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5909603834152222 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[1].display_name | Chemistry |
| concepts[2].id | https://openalex.org/C70721500 |
| concepts[2].level | 1 |
| concepts[2].score | 0.4375324547290802 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[2].display_name | Computational biology |
| concepts[3].id | https://openalex.org/C21951064 |
| concepts[3].level | 1 |
| concepts[3].score | 0.41654863953590393 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q899212 |
| concepts[3].display_name | Combinatorial chemistry |
| concepts[4].id | https://openalex.org/C98274493 |
| concepts[4].level | 1 |
| concepts[4].score | 0.3303714096546173 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[4].display_name | Pharmacology |
| concepts[5].id | https://openalex.org/C55493867 |
| concepts[5].level | 1 |
| concepts[5].score | 0.27794069051742554 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[5].display_name | Biochemistry |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.18035003542900085 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| concepts[7].id | https://openalex.org/C86803240 |
| concepts[7].level | 0 |
| concepts[7].score | 0.15144693851470947 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[7].display_name | Biology |
| concepts[8].id | https://openalex.org/C104317684 |
| concepts[8].level | 2 |
| concepts[8].score | 0.04958617687225342 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[8].display_name | Gene |
| keywords[0].id | https://openalex.org/keywords/in-silico |
| keywords[0].score | 0.9094047546386719 |
| keywords[0].display_name | In silico |
| keywords[1].id | https://openalex.org/keywords/chemistry |
| keywords[1].score | 0.5909603834152222 |
| keywords[1].display_name | Chemistry |
| keywords[2].id | https://openalex.org/keywords/computational-biology |
| keywords[2].score | 0.4375324547290802 |
| keywords[2].display_name | Computational biology |
| keywords[3].id | https://openalex.org/keywords/combinatorial-chemistry |
| keywords[3].score | 0.41654863953590393 |
| keywords[3].display_name | Combinatorial chemistry |
| keywords[4].id | https://openalex.org/keywords/pharmacology |
| keywords[4].score | 0.3303714096546173 |
| keywords[4].display_name | Pharmacology |
| keywords[5].id | https://openalex.org/keywords/biochemistry |
| keywords[5].score | 0.27794069051742554 |
| keywords[5].display_name | Biochemistry |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.18035003542900085 |
| keywords[6].display_name | Medicine |
| keywords[7].id | https://openalex.org/keywords/biology |
| keywords[7].score | 0.15144693851470947 |
| keywords[7].display_name | Biology |
| keywords[8].id | https://openalex.org/keywords/gene |
| keywords[8].score | 0.04958617687225342 |
| keywords[8].display_name | Gene |
| language | en |
| locations[0].id | doi:10.21203/rs.3.rs-7159986/v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.researchsquare.com/article/rs-7159986/latest.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.21203/rs.3.rs-7159986/v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5086753727 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Mohd. Faheem |
| authorships[0].countries | IN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I161370692 |
| authorships[0].affiliations[0].raw_affiliation_string | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[0].institutions[0].id | https://openalex.org/I161370692 |
| authorships[0].institutions[0].ror | https://ror.org/01rsgrz10 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I161370692 |
| authorships[0].institutions[0].country_code | IN |
| authorships[0].institutions[0].display_name | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mohd Faheem |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[1].author.id | https://openalex.org/A5112407464 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4494-7442 |
| authorships[1].author.display_name | Vaibhav Pandey |
| authorships[1].countries | IN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I161370692 |
| authorships[1].affiliations[0].raw_affiliation_string | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[1].institutions[0].id | https://openalex.org/I161370692 |
| authorships[1].institutions[0].ror | https://ror.org/01rsgrz10 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I161370692 |
| authorships[1].institutions[0].country_code | IN |
| authorships[1].institutions[0].display_name | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Vaibhav Pandey |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[2].author.id | https://openalex.org/A5009999025 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Manisha Prasad |
| authorships[2].countries | IN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I186246823 |
| authorships[2].affiliations[0].raw_affiliation_string | University of Lucknow |
| authorships[2].institutions[0].id | https://openalex.org/I186246823 |
| authorships[2].institutions[0].ror | https://ror.org/03bdeag60 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I186246823 |
| authorships[2].institutions[0].country_code | IN |
| authorships[2].institutions[0].display_name | University of Lucknow |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Manisha Prasad |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | University of Lucknow |
| authorships[3].author.id | https://openalex.org/A5009935024 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-9750-5029 |
| authorships[3].author.display_name | Manish Dixit |
| authorships[3].countries | IN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I161370692 |
| authorships[3].affiliations[0].raw_affiliation_string | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[3].institutions[0].id | https://openalex.org/I161370692 |
| authorships[3].institutions[0].ror | https://ror.org/01rsgrz10 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I161370692 |
| authorships[3].institutions[0].country_code | IN |
| authorships[3].institutions[0].display_name | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Manish Dixit |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.researchsquare.com/article/rs-7159986/latest.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | In-Silico Study of Thiazolidinone-linked Glu-Ureido based PSMA Ligands for PET Applications |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11440 |
| primary_topic.field.id | https://openalex.org/fields/16 |
| primary_topic.field.display_name | Chemistry |
| primary_topic.score | 0.9988999962806702 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1605 |
| primary_topic.subfield.display_name | Organic Chemistry |
| primary_topic.display_name | Click Chemistry and Applications |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2153919606, https://openalex.org/W2003194288, https://openalex.org/W2213189664, https://openalex.org/W2513589746, https://openalex.org/W2074002899, https://openalex.org/W2062254828, https://openalex.org/W4237480606, https://openalex.org/W2936968863, https://openalex.org/W1971792277 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.21203/rs.3.rs-7159986/v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.researchsquare.com/article/rs-7159986/latest.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-7159986/v1 |
| primary_location.id | doi:10.21203/rs.3.rs-7159986/v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.researchsquare.com/article/rs-7159986/latest.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-7159986/v1 |
| publication_date | 2025-09-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2155421560, https://openalex.org/W1982551773, https://openalex.org/W2750790860, https://openalex.org/W3153796617, https://openalex.org/W3016669909, https://openalex.org/W3088394919, https://openalex.org/W3120429776, https://openalex.org/W4313131228, https://openalex.org/W2743360501, https://openalex.org/W2126508060, https://openalex.org/W2324841752, https://openalex.org/W3183201628, https://openalex.org/W2952709614, https://openalex.org/W2921954224, https://openalex.org/W4307941926, https://openalex.org/W2149373951, https://openalex.org/W4322748147, https://openalex.org/W3185167154, https://openalex.org/W4283065687, https://openalex.org/W4388752692, https://openalex.org/W4405082576, https://openalex.org/W4405209112, https://openalex.org/W1970549136, https://openalex.org/W2023271753, https://openalex.org/W2147421370, https://openalex.org/W4226371412, https://openalex.org/W2396930286, https://openalex.org/W2946412700, https://openalex.org/W2593436234, https://openalex.org/W4393936599, https://openalex.org/W4395010444, https://openalex.org/W2801088198, https://openalex.org/W2336040088, https://openalex.org/W1887624773, https://openalex.org/W1970658820, https://openalex.org/W2158534713, https://openalex.org/W3168436232, https://openalex.org/W2218526232, https://openalex.org/W2167549547, https://openalex.org/W2151256267, https://openalex.org/W2043212464, https://openalex.org/W3127405048, https://openalex.org/W2103299776, https://openalex.org/W2144857097, https://openalex.org/W2025190578, https://openalex.org/W2023857477, https://openalex.org/W4402827247 |
| referenced_works_count | 47 |
| abstract_inverted_index.a | 9, 27 |
| abstract_inverted_index.10 | 68 |
| abstract_inverted_index.60 | 58 |
| abstract_inverted_index.II | 11 |
| abstract_inverted_index.In | 55 |
| abstract_inverted_index.as | 15, 91, 147, 257 |
| abstract_inverted_index.in | 20, 40, 262 |
| abstract_inverted_index.is | 8, 26 |
| abstract_inverted_index.of | 193, 265 |
| abstract_inverted_index.on | 61, 115 |
| abstract_inverted_index.to | 83 |
| abstract_inverted_index.II, | 18 |
| abstract_inverted_index.The | 2, 23, 94, 109, 154, 191 |
| abstract_inverted_index.and | 32, 45, 53, 67, 87, 106, 120, 133, 141, 158, 181, 208, 219, 240, 259 |
| abstract_inverted_index.are | 112, 167, 183, 242 |
| abstract_inverted_index.but | 202 |
| abstract_inverted_index.for | 30, 49, 150, 170, 187, 217, 254 |
| abstract_inverted_index.may | 203 |
| abstract_inverted_index.not | 196 |
| abstract_inverted_index.the | 125, 136, 151, 174, 176, 184, 214, 222, 227, 230, 263 |
| abstract_inverted_index.DFT, | 99, 118 |
| abstract_inverted_index.also | 204 |
| abstract_inverted_index.both | 41 |
| abstract_inverted_index.from | 221 |
| abstract_inverted_index.good | 155 |
| abstract_inverted_index.only | 197 |
| abstract_inverted_index.show | 37 |
| abstract_inverted_index.that | 163 |
| abstract_inverted_index.them | 146 |
| abstract_inverted_index.this | 56 |
| abstract_inverted_index.type | 10 |
| abstract_inverted_index.used | 35 |
| abstract_inverted_index.were | 65, 70, 96 |
| abstract_inverted_index.with | 245 |
| abstract_inverted_index.ADMET | 100 |
| abstract_inverted_index.Among | 124, 173, 226 |
| abstract_inverted_index.PSMA, | 31 |
| abstract_inverted_index.PSMA. | 152, 248 |
| abstract_inverted_index.These | 77, 211, 249 |
| abstract_inverted_index.atoms | 82, 195 |
| abstract_inverted_index.based | 60, 114 |
| abstract_inverted_index.known | 14 |
| abstract_inverted_index.mimic | 84 |
| abstract_inverted_index.other | 121, 143, 159 |
| abstract_inverted_index.score | 157 |
| abstract_inverted_index.their | 89 |
| abstract_inverted_index.these | 33 |
| abstract_inverted_index.using | 73, 98 |
| abstract_inverted_index.(PSMA) | 7 |
| abstract_inverted_index.THL04, | 236 |
| abstract_inverted_index.THL06, | 237 |
| abstract_inverted_index.THL07, | 238 |
| abstract_inverted_index.THL08, | 239 |
| abstract_inverted_index.THL10, | 241 |
| abstract_inverted_index.cancer | 189 |
| abstract_inverted_index.energy | 139 |
| abstract_inverted_index.future | 255 |
| abstract_inverted_index.lowest | 137 |
| abstract_inverted_index.moiety | 25 |
| abstract_inverted_index.passed | 142 |
| abstract_inverted_index.potent | 148, 215, 243 |
| abstract_inverted_index.scores | 140 |
| abstract_inverted_index.study, | 57 |
| abstract_inverted_index.target | 116 |
| abstract_inverted_index.toward | 247 |
| abstract_inverted_index.widely | 34 |
| abstract_inverted_index.Antigen | 6 |
| abstract_inverted_index.Methods | 54 |
| abstract_inverted_index.Results | 108 |
| abstract_inverted_index.agents. | 93 |
| abstract_inverted_index.binding | 138, 207 |
| abstract_inverted_index.cancer. | 51, 267 |
| abstract_inverted_index.docking | 105, 156 |
| abstract_inverted_index.enhance | 205 |
| abstract_inverted_index.imaging | 44, 92, 218 |
| abstract_inverted_index.ligands | 64, 69 |
| abstract_inverted_index.nuclear | 43 |
| abstract_inverted_index.results | 39 |
| abstract_inverted_index.suggest | 162 |
| abstract_inverted_index.support | 213 |
| abstract_inverted_index.tagging | 201 |
| abstract_inverted_index.various | 74 |
| abstract_inverted_index.Membrane | 5 |
| abstract_inverted_index.Prostate | 3 |
| abstract_inverted_index.Specific | 4 |
| abstract_inverted_index.designed | 66, 78 |
| abstract_inverted_index.evaluate | 88 |
| abstract_inverted_index.findings | 212 |
| abstract_inverted_index.fluorine | 81, 194 |
| abstract_inverted_index.imaging. | 172, 190 |
| abstract_inverted_index.library, | 175, 229 |
| abstract_inverted_index.ligands, | 233 |
| abstract_inverted_index.presence | 192 |
| abstract_inverted_index.prostate | 21, 50, 188, 266 |
| abstract_inverted_index.receptor | 206 |
| abstract_inverted_index.screened | 72, 113, 126 |
| abstract_inverted_index.selected | 110, 122, 223, 228 |
| abstract_inverted_index.toxicity | 102, 119 |
| abstract_inverted_index.Glutamate | 16 |
| abstract_inverted_index.Materials | 52 |
| abstract_inverted_index.analysis, | 103 |
| abstract_inverted_index.compounds | 95 |
| abstract_inverted_index.dynamics. | 107 |
| abstract_inverted_index.evaluated | 97 |
| abstract_inverted_index.exhibited | 135 |
| abstract_inverted_index.in-silico | 75 |
| abstract_inverted_index.inhibitor | 29 |
| abstract_inverted_index.molecular | 104, 209 |
| abstract_inverted_index.molecules | 111 |
| abstract_inverted_index.potential | 90, 199 |
| abstract_inverted_index.promising | 38, 168, 185, 252 |
| abstract_inverted_index.represent | 251 |
| abstract_inverted_index.scaffolds | 59, 79, 149, 166, 186, 216, 244, 250 |
| abstract_inverted_index.simulates | 198 |
| abstract_inverted_index.virtually | 71 |
| abstract_inverted_index.Conclusion | 225 |
| abstract_inverted_index.Discussion | 153 |
| abstract_inverted_index.Glu-Ureido | 24 |
| abstract_inverted_index.PSMA-THL08 | 132 |
| abstract_inverted_index.PSMA-THL10 | 134, 182 |
| abstract_inverted_index.approaches | 86 |
| abstract_inverted_index.candidates | 169, 253 |
| abstract_inverted_index.carcinoma. | 22 |
| abstract_inverted_index.compounds, | 127 |
| abstract_inverted_index.diagnostic | 258 |
| abstract_inverted_index.indicating | 145 |
| abstract_inverted_index.inhibitors | 36 |
| abstract_inverted_index.management | 264 |
| abstract_inverted_index.profiling, | 101 |
| abstract_inverted_index.properties | 161 |
| abstract_inverted_index.stability. | 210 |
| abstract_inverted_index.PSMA-THL02, | 128, 177, 235 |
| abstract_inverted_index.PSMA-THL04, | 129 |
| abstract_inverted_index.PSMA-THL06, | 130, 178 |
| abstract_inverted_index.PSMA-THL07, | 131, 179 |
| abstract_inverted_index.PSMA-THL08, | 180 |
| abstract_inverted_index.candidates. | 224 |
| abstract_inverted_index.development | 256 |
| abstract_inverted_index.parameters, | 144 |
| abstract_inverted_index.parameters. | 76, 123 |
| abstract_inverted_index.prediction, | 117 |
| abstract_inverted_index.specificity | 246 |
| abstract_inverted_index.therapeutic | 47, 260 |
| abstract_inverted_index.applications | 48 |
| abstract_inverted_index.glycoprotein | 13 |
| abstract_inverted_index.incorporated | 80 |
| abstract_inverted_index.non-invasive | 42 |
| abstract_inverted_index.particularly | 234 |
| abstract_inverted_index.radionuclide | 200 |
| abstract_inverted_index.radiotracers | 261 |
| abstract_inverted_index.therapeutics | 220 |
| abstract_inverted_index.Introduction: | 1 |
| abstract_inverted_index.PSMA-targeted | 171 |
| abstract_inverted_index.overexpressed | 19 |
| abstract_inverted_index.transmembrane | 12 |
| abstract_inverted_index.radiolabelling | 85 |
| abstract_inverted_index.thiazolidinone | 165, 232 |
| abstract_inverted_index.physicochemical | 160 |
| abstract_inverted_index.target-specific | 28 |
| abstract_inverted_index.Carboxypeptidase | 17 |
| abstract_inverted_index.Glu-Ureido-based | 231 |
| abstract_inverted_index.Glu-Ureido-linked | 62, 164 |
| abstract_inverted_index.radionuclide-based | 46 |
| abstract_inverted_index.thiazolidinone-based | 63 |
| abstract_inverted_index.<title>Abstract</title> | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile.value | 0.31864543 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |